ConductScience.org, home

Trial · NCT01155479

Participant flow35

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Part ISTARTEDPreladenant 2 mg204
Part ISTARTEDPreladenant 5 mg204
Part ISTARTEDPreladenant 10 mg206
Part ISTARTEDPlacebo204
Part ISTARTEDRasagiline204
Part ITreatedPreladenant 2 mg200
Part ITreatedPreladenant 5 mg202
Part ITreatedPreladenant 10 mg204
Part ITreatedPlacebo198
Part ITreatedRasagiline203
Part ICOMPLETEDPreladenant 2 mg166
Part ICOMPLETEDPreladenant 5 mg177
Part ICOMPLETEDPreladenant 10 mg167
Part ICOMPLETEDPlacebo177
Part ICOMPLETEDRasagiline181
Part INOT COMPLETEDPreladenant 2 mg38
Part INOT COMPLETEDPreladenant 5 mg27
Part INOT COMPLETEDPreladenant 10 mg39
Part INOT COMPLETEDPlacebo27
Part INOT COMPLETEDRasagiline23

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01155479/flow